[Interrelation of the blood kallikrein-kinin and anticoagulation systems in experimental myocardial infarct]. 1981

A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko

The activity of the kallikrein-kinin and anticoagulation blood systems was studied in dogs with experimental myocardial infarction. Changes were revealed in the kallikrein-kinin system which create conditions for uncontrolled production of kinins in the first 24 hours of the disease. A direct correlation was detected between the activity of kallikrein and plasmin in the first three days of experimental myocardial infarction, which the authors claim to be a pathophysiological reaction of the body because it is conductive to the uncontrolled production of kinins. It is also noted that in this pathological process the depression of the anticoagulation system in the first two days is mainly due to reduced activity of nonenzymatic fibrinolysis, while, beginning with the third day, it is caused by reduced activity of enzymatic fibrinolysis, increased antiplasmin activity in particular.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
May 1974, Die Medizinische Welt,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
August 1984, Vrachebnoe delo,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
January 1978, Voprosy meditsinskoi khimii,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
September 1986, Kardiologiia,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
August 1986, Kardiologiia,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
January 1984, Klinicheskaia meditsina,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
January 1975, Voprosy meditsinskoi khimii,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
January 1985, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
November 1980, Vrachebnoe delo,
A G Ponomareva, and Iu A Churakov, and R A Trapezontseva, and S B Stepanenko
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!